Disc Medicine (IRON) Enterprise Value (2022 - 2026)

Disc Medicine (IRON) has reported Enterprise Value for 7 consecutive years, with -$717.7 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Enterprise Value fell 10.43% year-over-year to -$717.7 million; the TTM figure through Jun 2026 stood at -$717.7 million (down 10.43% YoY), while the FY2025 annual figure was -$791.2 million, down 61.5% from the prior year.
• Enterprise Value rose to -$717.7 million in Q2 2026 per IRON's latest filing, from -$730.2 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$101.7 million in Q3 2022 and bottomed at -$791.2 million in Q4 2025.
• Historically, Enterprise Value has averaged -$438.3 million across 5 years, with a median of -$432.5 million in 2023.
• Annual changes were most pronounced in 2022 — Enterprise Value soared 35.44% — and 2023, when it sank 264.21%.
• Disc Medicine's Enterprise Value stood at -$194.6 million in 2022, then sank by 85.18% to -$360.4 million in 2023, then plunged by 35.93% to -$489.9 million in 2024, then slumped by 61.5% to -$791.2 million in 2025, then increased by 9.28% to -$717.7 million in 2026.
• Business Quant data shows IRON's Enterprise Value at -$717.7 million in Q2 2026, -$730.2 million in Q1 2026, and -$791.2 million in Q4 2025.